DENVER, CO / April 17, 2018 / AmeriCann, Inc. (OTCQB: ACAN), an Agricultural-Technology company that is developing the next generation of sustainable, state-of-the-art cannabis cultivation properties, commented on the recent news of new political support for cannabis from President Donald Trump.

According to Senator Cory Gardner (R-CO) President Trump provided him with a commitment to protect states’ rights with respect to cannabis policies as well as assurances that the President would back a permanent legislative solution.

“Since the campaign, President Trump has consistently supported states’ rights to decide for themselves how best to approach marijuana,” said Gardner. “Late Wednesday, I received a commitment from the President that the Department of Justice’s rescission of the Cole memo will not impact Colorado’s legal marijuana industry. Furthermore, President Trump has assured me that he will support a federalism-based legislative solution to fix this states’ rights issue once and for all.”

White House legislative affairs director Marc Short confirmed Senator Gardner’s reports on Friday.

“We are encouraged by these assurances from President Trump and the bipartisan efforts of Senator Gardner and others,” stated AmeriCann President and CEO Tim Keogh. “We have believed that it is not a question of if, but when the prohibition of marijuana would be repealed at the federal level. The multi-billion dollar cannabis industry is poised to expand significantly should federal obstacles be removed.”

National support for cannabis has reached record levels. Examples of this includes the following:

• A Gallup poll released in October showed that 64% of Americans support making marijuana legal for adults.
• This was also the first time in this annual poll that a majority of Republicans polled supported legalization.
• A CBS News poll released in April 2017 showed that 71% do not think the federal government should interfere in state marijuana laws.
• Twenty-nine states, the District of Columbia, and the U.S. territories of Guam and Puerto Rico have enacted effective medical marijuana laws. Marijuana is legal and regulated for adults in eight states.
• More than 20 states are expected to consider bills to regulate marijuana this year.

AmeriCann is developing the Massachusetts Medical Cannabis Center (MMCC), a state-of-the-art cannabis cultivation and processing development in the midst of the rapidly growing Massachusetts medical cannabis market. The MMCC project is approved for 1 million square feet, which will be developed in phases and is expected to be one of the most technologically advanced cultivation facilities in the nation.

About AmeriCann

AmeriCann (OTCQX: ACAN) is a publicly traded Agricultural Technology (Ag-Tech) company that is developing a new generation of sustainable, state-of-the-art medical cannabis cultivation and processing properties.

AmeriCann, Inc. is a Certified B Corp, an acknowledgment of the company’s commitment to social and environmental ethics, transparency and accountability. AmeriCann became the first public cannabis company to earn this respected accreditation. More information about the Company is available at: www.americann.co, or follow AmeriCann on Twitter@ACANinfo.

About Massachusetts Medical Cannabis Center (MMCC)

The Massachusetts Medical Cannabis Center is approved for nearly 1,000,000 square feet of medical cannabis cultivation and processing in Freetown, Massachusetts. The state-of-the-art, sustainable, greenhouse project will consist of multiple planned phases for tenants in the Massachusetts medical marijuana market. Voters in Massachusetts approved legalizing the adult use of recreational marijuana in November of 2016. The state is on track to open the first cannabis storefronts for Adult-Use by July 1, 2018, making Massachusetts the first state in the Northeast to legalize cannabis.

AmeriCann’s Cannopy System uniquely combines expertise from traditional horticulture, lean manufacturing, regulatory compliance and cannabis cultivation to create superior facilities and procedures. The company is planning to replicate the Canopy platform in additional states.